Sonus Pharmaceuticals, Inc.'s (Both...
Sonus Pharmaceuticals, Inc.'s (Bothell, WA) lead cancer outcome TOCOSOL Paclitaxel, continues to present to view favorable antitumor activity, including clean and partial responses, in cancer enslaves who have failed prior chemotherapeutic regimens. The thought drug also demonstrates worthy tolerability over multiple treatment periods As a result, in the greatest degree subjects receiving it do not ne doses reduc or
|